Process for the manufacture of an ophthalmic molding
First Claim
1. A process for the manufacture of a molding, which comprises the following steps:
- a) providing at least one prepolymer comprising one or more crosslinkable groups, wherein the prepolymer is an amphiphilic segmented copolymer comprising at least one hydrophobic segment and one hydrophilic segment;
b) preparing an at least partly bicontinuous mesophase of the prepolymer by combining the prepolymer with an aqueous solution at a ratio that will give a microstructure which is at least partly bicontinuous and causing or allowing the bicontinuous microstructure to form;
c) introducing the mesophase obtained into an ophthalmic mold;
d) crosslinking the prepolymer to form the molding; and
e) opening the mold such that the molding can be removed.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention relates to a process for the manufacture of a molding, which comprises the following steps:
a) providing at least one prepolymer comprising one or more crosslinkable groups, wherein the prepolymer is an amphiphilic segmented copolymer comprising at least one hydrophobic segment A and one hydrophilic segment B;
b) preparing a mesophase of the prepolymer which is at least partly bicontinuous;
c) introducing the mesophase obtained into an ophthalmic mold;
d) triggering of the crosslinking; and
e) opening the mold such that the molding can be removed. The process of the invention is particularly suited for the manufacture of membranes and ophthalmic moldings such as contact lenses.
280 Citations
24 Claims
-
1. A process for the manufacture of a molding, which comprises the following steps:
-
a) providing at least one prepolymer comprising one or more crosslinkable groups, wherein the prepolymer is an amphiphilic segmented copolymer comprising at least one hydrophobic segment and one hydrophilic segment; b) preparing an at least partly bicontinuous mesophase of the prepolymer by combining the prepolymer with an aqueous solution at a ratio that will give a microstructure which is at least partly bicontinuous and causing or allowing the bicontinuous microstructure to form; c) introducing the mesophase obtained into an ophthalmic mold; d) crosslinking the prepolymer to form the molding; and e) opening the mold such that the molding can be removed. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)
-
11. A process according to claim 1, wherein the prepolymer comprises at least one segment of the formula (VI):
- ##STR14## in which (a) is a polysiloxane segment,
(b) is a polyol segment which contains at least 4 C atoms, Z1 is a segment X2 --R'"'"'--X2 or a group X1, R'"'"' is a bivalent radical of an organic compound having up to 20 C atoms and X1 and each X2 independently of the other are a bivalent radical which contains at least one carbonyl group, and (d) is a radical of the formula (VII);
##STR15## in which P1 is a group which can be polymerized by free radicals;Y and X3 independently of one another are a bivalent radical which contains at least one carbonyl group; k1 is 0 or 1; and L is a bond or a divalent radical having up to 20 C atoms of an organic compound.
- ##STR14## in which (a) is a polysiloxane segment,
-
12. A process according to claim 1, wherein the mesophase is prepared by combining two or more prepolymers, with an aqueous solution.
-
13. A process according to claim 12, wherein the aqueous solution comprises pure water or a mixture of water and one or more water-miscible solvents and/or salts.
-
14. A process according to claim 1, wherein the mesophase is prepared by combining the prepolymer with an aqueous solution and one or more components selected from the group consisting of a photoinitiator, a thermal initiator, a redox initiator, a surfactant, a comonomer, a comacromer and a pharmaceutical effective agent.
-
15. A process according to claim 1, wherein the mesophase is prepared from the prepolymer;
- water which may contain physiologically acceptable salts; and
optionally a photoinitiator and/or an additional solvent selected from the group consisting of a monohydric or polyhydric alcohol, a polyether, a carboxylic acid amide, acetone, acetonitrile and dimethyl sulfoxide.
- water which may contain physiologically acceptable salts; and
-
16. A process according to claim 1, wherein the mesophase is prepared from the prepolymer, water and optionally a photoinitiator.
-
17. A process according to claim 1, wherein the bicontinuous microstructure is caused to form by admixing the prepolymer, the aqueous solution and optionally further components selected from the group consisting of a photoinitiator, a thermal initiator, a redox initiator, a surfactant, a comonomer, a comacromer, and a pharmaceutical effective agent;
- and keeping the mixture at a temperature of 0 to 100°
C. for a time period from 1 minute to 1 week with optional stirring.
- and keeping the mixture at a temperature of 0 to 100°
-
18. A process according to claim 1, wherein the formation of the mesophase comprises preparing a melt of the prepolymer and optionally further components selected from the group consisting of a photoinitiator, a thermal initiator, a redox initiator, a surfactant, a comonomer, a comacromer, and a pharmaceutical effective agent.
-
19. A process according to claim 1, wherein the mesophase obtained according to step b) is of a crystalline structure.
-
20. A process according to claim 1, wherein the crosslinking is carried out for a time period of ≦
- 60 minutes.
-
21. A process according to claim 1, wherein the molding is a contact lens.
-
22. A contact lens, obtainable according to the process of claim 1.
-
23. A process according to claim 1, wherein the molding is a membrane.
-
24. A membrane, obtainable according to the process of claim 1.
-
Specification